Adipocyte PHLPP2 inhibition prevents obesity-induced fatty liver
Obesity can be associated with an increased risk of metabolic complications. Here, the authors show that adipocyte-specific ablation of the phosphatase PHLPP2 improves glucose homeostasis in high-fat diet fed obese mice, and that this may be due at least in part to PHLPP2 dephosphorylation of HSL.
Enregistré dans:
Auteurs principaux: | KyeongJin Kim, Jin Ku Kang, Young Hoon Jung, Sang Bae Lee, Raffaela Rametta, Paola Dongiovanni, Luca Valenti, Utpal B. Pajvani |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/fbedf8ee43a14e308e77f09b74b4c302 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
mTORC1-independent Raptor prevents hepatic steatosis by stabilizing PHLPP2
par: KyeongJin Kim, et autres
Publié: (2016) -
Obesity, adipocyte hypertrophy, fasting glucose, and resistin are potential contributors to nonalcoholic fatty liver disease in South Asian women
par: Albracht-Schulte K, et autres
Publié: (2019) -
Advanced lipodystrophy reverses fatty liver in mice lacking adipocyte hormone-sensitive lipase
par: Laura Pajed, et autres
Publié: (2021) -
Maternal tadalafil therapy for fetal growth restriction prevents non-alcoholic fatty liver disease and adipocyte hypertrophy in the offspring
par: Takuya Kawamura, et autres
Publié: (2021) -
Obesity and nonalcoholic fatty liver disease: current perspectives
par: Sarwar R, et autres
Publié: (2018)